Position in QGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,848,400
New position
Shares Held
124,000
first reported quarter
Ownership
0.060%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#101
of 336 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in QGEN
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$175,950
PutShares
4,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Axxion S.A. holds $8,667,740 across 9 Diagnostics & Research names. QGEN ranks #1 (55.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | QGEN |
Qiagen N.V.
This page
|
124,000 | $4,848,400 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
2,237 | $1,121,542 | |
| 3 | WAT |
Waters Corp /De/
|
1,276 | $478,551 | |
| 4 | DHR |
Danaher Corp /De/
|
2,315 | $440,961 | |
| 5 | RVTY |
Revvity, Inc.
|
3,700 | $411,662 | |
| 6 | ICLR |
Icon PLC
|
2,300 | $399,533 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,800 | $381,510 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
1,800 | $347,796 |
All Filings in QGEN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $175,950 | 4,500 | Put | Sole | 2026-08-14 | |
| 2026-06-30 | $4,848,400 | 124,000 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||